University College London Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
University of Sussex Featured PhD Programmes
Birkbeck, University of London Featured PhD Programmes
University College London Featured PhD Programmes
"group"×
10 miles

Cancer / Oncology (group) PhD Projects, Programs & Scholarships

We have 157 Cancer / Oncology (group) PhD Projects, Programs & Scholarships

  • "group" ×
  • Cancer / Oncology×
  • clear all
Order by 
Showing 1 to 30 of 157
  Cancer Research UK 4 Year PhD Studentships – September 2020

Funding Type

PhD Type

Cancer Research UK 4 Year PhD Studentships – September 2020. The Cancer Research UK Manchester Institute [CRUK MI] is a world-leading cancer centre of excellence within The University of Manchester, core funded by Cancer Research UK, the largest independent cancer research organisation in the world.
  Transglutaminase 2 (TG2) as a novel cancer biomarker and target for chemotherapy
  Research Group: Biomedical Research Group
  Dr P Coussons, Dr C Pike
Applications accepted all year round

Funding Type

PhD Type

Research Group. Biomedical Research Group. https://www.anglia.ac.uk/science-and-engineering/research/institutes-and-groups/biomedical.
  Molecular mechanisms regulating the developmental plasticity of pancreatic cancer cells #NDORMS-2020/6
  Dr S Pauklin
Application Deadline: 10 January 2020

Funding Type

PhD Type

Pancreatic cancers are among the most lethal malignancies in human due to highly metastatic characteristics and the poor responsiveness to currently used cancer therapeutics.
  An intelligent scheme to identify novel drug targets through analysing the DNA repairome in drug resistant cancer?
  Research Group: Biomedical Research Group
  Prof C Parris
Applications accepted all year round

Funding Type

PhD Type

Research Group. Biomedical Research Group. https://www.anglia.ac.uk/science-and-engineering/research/institutes-and-groups/biomedical.
  Development of new drugs to reverse tumour resistance to chemotherapy
  Research Group: Biomedical Research Group
  Dr C Erridge, Dr G Pirianov
Applications accepted all year round

Funding Type

PhD Type

Research Group. Biomedical Research Group. https://www.anglia.ac.uk/science-and-engineering/research/institutes-and-groups/biomedical.
  Investigating the anti-cancer effect of hop β -acid Lupulone and its synthetic derivatives on breast cancer cells
  Research Group: Biomedical Research Group
  Dr G Pirianov
Applications accepted all year round

Funding Type

PhD Type

Research Group. Biomedical Research Group. https://www.anglia.ac.uk/science-and-engineering/research/institutes-and-groups/biomedical.
  Dissecting cancer immunogenicity to enhance therapy response
  Dr S Zelenay
Application Deadline: 3 January 2020

Funding Type

PhD Type

This 4 year PhD studentship offered in Dr Santiago Zelenay’s research group is based at the Cancer Research UK Manchester Institute, Alderley Park, Cheshire.
  The Genomics of Hereditary Prostate Cancer
  Prof R Bristow
Application Deadline: 3 January 2020

Funding Type

PhD Type

This 4 year PhD studentship offered in Professor Rob Bristow’s research group is based at the Cancer Research UK Manchester Institute, Manchester Cancer Research Centre, Oglesby Cancer Research Building, Manchester.
  Therapeutic opportunities in mutant p53 cancer cells
  Dr P Muller
Application Deadline: 3 January 2020

Funding Type

PhD Type

This 4 year PhD studentship offered in Dr Patricia Muller’s research group is based at the Cancer Research UK Manchester Institute, Alderley Park, Cheshire.
  EastBio Untangling the role of microglia in colonising brain tumours through targeted drug delivery
  Prof A N Hulme, Dr D Sieger, Prof V Brunton
Application Deadline: 5 January 2020

Funding Type

PhD Type

A PhD studentship is available in the group of Professor Alison Hulme (School of Chemistry, The University of Edinburgh; https://hulmegroup.wordpress.com/).
  Role of m6A reader proteins in virus infection
  Research Group: BBSRC White Rose DTP
  Prof A Whitehouse, Dr A.K Tuplin
Application Deadline: 6 January 2020

Funding Type

PhD Type

RNA is an intermediate molecule in the flow of genetic information from DNA to protein. It is a critical junction for the cell to regulate gene expression, through multiple RNA processing events.
  MRC DiMeN Doctoral Training Partnership: Developing protein tools to target DNA damage response and repair in cancer cells
  Dr Q. Wu, Dr D Tomlinson
Application Deadline: 6 January 2020

Funding Type

PhD Type

DNA damage response (DDR) and repair play critical roles in influencing the efficiency and sensitivity of many cancer treatments.
  MRC DiMeN Doctoral Training Partnership: Role of RNA modifications in virus infection
  Prof A Whitehouse, Prof S Wilson
Application Deadline: 6 January 2020

Funding Type

PhD Type

As an intermediate molecule in the flow of genetic information, RNA offers a critical junction in the cell to regulate many cellular processes that underpin cell biology, development and tissue function.
  Pre-clinical investigations of POLQ inhibitors
  Dr G Higgins, Prof T Humphrey
Application Deadline: 10 January 2020

Funding Type

PhD Type

THE PROJECT. The aim of our research is to improve radiotherapy for cancer patients by making tumour cells more sensitive to radiation without affecting the sensitivity of normal cells.
  Artificial intelligence and machine learning for clinical prediction: Evaluating design, conduct, reporting and 'spin' #NDORMS-2020/3
  Prof G Collins, Dr M Schlussel, Dr P Dhiman, Dr J de Beyer
Application Deadline: 10 January 2020

Funding Type

PhD Type

1. Professor Gary Collins. 2. Dr Michael Schlussel. 3. Dr Paula Dhiman. 4. Dr Jennifer de Beyer. Artificial intelligence (AI) and machine learning (ML) are increasingly seen as solutions to many healthcare problems (e.g., for risk prediction, imaging), and the pace of development is showing no signs abating.
  Academic Endocrine Unit: investigating the molecular basis of endocrine and metabolic disorders that principally affect calcium and phosphate homeostasis.
  Prof R Thakker, Dr K Lines, Dr M Stevenson, Dr K Kooblall
Application Deadline: 10 January 2020

Funding Type

PhD Type

Other Potential Supervisors. Dr Asha Bayliss. The Academic Endocrine Unit investigates the molecular basis of endocrine and metabolic disorders that principally affect calcium and phosphate homeostasis.
  Identification of key determinants affecting the quality of human Cancer specific cytotoxic T cells
  Prof T Dong
Application Deadline: 10 January 2020

Funding Type

PhD Type

The main objective of my group’s research is to focus on the functional aspects of the antigen specific T cells and study the factors affecting Cytotoxic T cells in controlling cancer development.
  Identification of key determinants affecting the quality of human Cancer specific cytotoxic T cells
  Prof T Dong
Application Deadline: 10 January 2020

Funding Type

PhD Type

The main objective of my group’s research is to focus on the functional aspects of the antigen specific T cells and study the factors affecting Cytotoxic T cells in controlling cancer development.
  Targeting the Gas6-TAM receptor signalling pathway in cancer
  Dr S Hafizi
Applications accepted all year round

Funding Type

PhD Type

Applications are invited for a self-funded 3 year full-time PhD project, to commence in October 2019 or February 2020. The PhD will be based in the School of Pharmacy and Biomedical Sciences and will be supervised by Dr Sassan Hafizi.
  TRIB3 at the interface of metabolism and inflammation in adipose tissue
  Dr H Wilson, Prof E Kiss-Toth
Applications accepted all year round

Funding Type

PhD Type

Obesity drives chronic inflammation and immune activation. This results in dysregulated metabolism, insulin resistance linked to diabetes, cardiovascular disease and cancer.
  MRC DiMeN Doctoral Training Partnership: DUB-ing chronic inflammation: a drug repurposing approach to target deubiquitinases in inflammatory disease
  Dr H Ismail, Prof S Renshaw, Dr L Guo
Application Deadline: 6 January 2020

Funding Type

PhD Type

Background. Inflammation is an essential defence mechanism adapted by our bodies to eliminate damaged cells, irritants and pathogens.
  Exploring epigenetic heterogeneity in isogenic cancer models……one cell at a time
  Dr M Portal
Application Deadline: 3 January 2020

Funding Type

PhD Type

This 4 year PhD studentship offered in Dr Maximiliano Portal’s research group is based at the Cancer Research UK Manchester Institute, Alderley Park, Cheshire.
  Investigation of novel HOX interactors as potential therapeutic targets in leukaemia
  Prof G Lacaud
Application Deadline: 3 January 2020

Funding Type

PhD Type

This 4 year PhD studentship offered in Professor Georges Lacaud’s research group is based at the Cancer Research UK Manchester Institute, Alderley Park, Cheshire.
  MANCAN - an integrated clinical and blood based multi-analyte readout
  Prof C Dive
Application Deadline: 3 January 2020

Funding Type

PhD Type

This 4 year PhD studentship offered in Professor Caroline Dive’s research group is based at the Cancer Research UK Manchester Institute, Alderley Park, Cheshire.
  Why do aged melanoma patients respond better to IT?
  Dr A Viros
Application Deadline: 3 January 2020

Funding Type

PhD Type

This 4 year PhD studentship offered in Dr Amaya Virós’s research group is based at the Cancer Research UK Manchester Institute, Alderley Park, Cheshire.
  Machine Learning regulation at the 3’ UTR
  Dr C Miller
Application Deadline: 3 January 2020

Funding Type

PhD Type

The 3’ Untranslated Region (UTR) of a transcript presents a complex set of binding sites that are used to regulate both transcript stability and downstream protein translation.
  Regulation of cancer cell metabolism by mechanical tissue cues
  Dr H Auner
Application Deadline: 15 January 2020

Funding Type

PhD Type

Stipend. £18,000 (inclusive of London allowance) per annum + Tuition Fees (Home/EU rate) for 3 years. A consumables budget is also provided.
  Fueling chemotherapy resistance in triple-negative breast cancer
  Dr K Brown
Applications accepted all year round

Funding Type

PhD Type

Triple-negative breast cancer (TNBC) is a molecularly heterogeneous group of diseases defined by the lack of estrogen receptor (ER), progesterone receptor (PR) and absence of human epidermal growth factor receptor-2 (HER2) amplification.
  The role of the breast microenvironment in suppressing early cancer invasion
  Assoc Prof B Parker, Dr D Zanker
Applications accepted all year round

Funding Type

PhD Type

Ductal carcinoma in situ (DCIS) is a pre-invasive stage of breast cancer, whereby the tumour cells remain restrained by myoepithelial cells that surround breast ducts.
  Transcriptional heterogeneity and resistance to therapy in prostate cancer
  Dr D. Goode
Applications accepted all year round

Funding Type

PhD Type

Androgen deprivation therapy (ADT) is a standard treatment for prostate cancer that works well in many cases but rapidly fails in others.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.